Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review: Anti-IL-17 Agents for Psoriatic Disease Pipeline
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-08-14 16:40:47 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
D Kim, S Yang, M Gill, N Babaei, M Cervantes…
American Journal of …, 2025
Springer
… , S‑011806) and DC‑853 (LY‑4100511) DC-806 and DC-853 are both orally administered
small molecule IL-17 inhibitors. DC-806 is the lead candidate, while DC-853 is a fast-follower …

